The Valley Desk

NCT06788756 · Interventional trial

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Overall registry status Recruiting

Phase 2 · Phase 3

Conditions Acute Myeloid Leukaemia (AML)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov